# Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)

> **NCT01977443** · PHASE2 · COMPLETED · sponsor: **Adenovir Pharma AB** · enrollment: 47 (actual)

## Conditions studied

- Viral Conjunctivitis

## Interventions

- **DRUG:** APD-209 Eye drops
- **DRUG:** APD-209 Placebo Eye drops

## Key facts

- **NCT ID:** NCT01977443
- **Lead sponsor:** Adenovir Pharma AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2016-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01977443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01977443, "Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01977443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*